There's lots of excitement about the new protease inhibitors

April 1996

There's lots of excitement about the new protease inhibitors...because of their dramatic effects on suppressing the HIV virus.

The FDA approved the first protease inhibitor, saquinavir (Invirase), in December.

Now there's ritonavir (Norvir) and indinavir (Crixivan). These latest two drugs seem to be more active against HIV than the first one.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote